High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: High tolerability with reversible cardiotoxicity

C. Tarella, F. Zallio, D. Caracciolo, A. Cuttica, P. Corradini, P. Gavarotti, M. Ladetto, V. Podio, A. Sargiotto, G. Rossi, A. M. Gianni, A. Pileri

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: High tolerability with reversible cardiotoxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences